EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual‐Mechanism Peptide SR25 has Broad Antimicrobial Activity and Potential Application for Healing Bacteria‐infected Diabetic Wounds

Xue-Yue Luo, Chun-Mei Hu, Qi Yin, Xiao-Mei Zhang, Zhen-Zhen Liu, Cheng-Kai Zhou, Jian-Gang Zhang, Wei Chen, Yong-Jun Yang iD

Advanced Science · 2024-08 · 11 (30)

DOI: 10.1002/advs.202401793 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 14.06.2024. Verfasst von Xue-Yue Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin, 130062, P. R. China. Hauptthemen laut MEDLINE: Wound Healing, Disease Models, Animal, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of antibiotic resistance poses a significant public health crisis, particularly due to limited antimicrobial options for the treatment of infections with Gram‐negative pathogens. Here, an antimicrobial peptide (AMP) SR25 is characterized, which effectively kills both Gram‐negative and Gram‐positive bacteria through a unique dual‐targeting mechanism without detectable resistance. Meanwhile, an SR25‐functionalized hydrogel is developed for the efficient treatment of infected diabetic wounds. SR25 is obtained through genome mining from an uncultured bovine enteric actinomycete named Nonomuraea Jilinensis sp. nov. Investigations reveal that SR25 has two independent cellular targets, disrupting bacterial membrane integrity and restraining the activity of succinate:quinone oxidoreductase (SQR). In a diabetic mice wound infection model, the SR25‐incorporated hydrogel exhibits high efficacy against mixed infections of Escherichia coli ( E. coli ) and methicillin‐resistant Staphylococcus aureus (MRSA), accelerating wound healing. Overall, these findings demonstrate the therapeutic potential of SR25 and highlight the value of mining drugs with multiple mechanisms from uncultured animal commensals for combating challenging bacterial pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingDisease Models, AnimalDiabetes Mellitus, ExperimentalAnimalsMiceMethicillin-Resistant Staphylococcus aureusAntimicrobial PeptidesWound InfectionAnti-Bacterial AgentsEscherichia coliMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antimicrobial peptidesdiabetic woundhydrogelmembrane disruptingsuccinate:quinone reductaseuncultured bacteria

Substanzen

Antimicrobial PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Preventive Veterinary Medicine, College of Veterinary Medicine, Jilin University, Changchun, Jilin, 130062, P. R. China.

ORCID-Profile: Yong-Jun Yang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Luo, X. Y., Hu, C. M., Yin, Q., Zhang, X. M., Liu, Z. Z., Zhou, C. K., Zhang, J. G., Chen, W., & Yang, Y. J. (2024). Dual‐Mechanism Peptide SR25 has Broad Antimicrobial Activity and Potential Application for Healing Bacteria‐infected Diabetic Wounds. Advanced Science, 11(30). https://doi.org/10.1002/advs.202401793

Vancouver

Luo XY, Hu CM, Yin Q, Zhang XM, Liu ZZ, Zhou CK, et al. Dual‐Mechanism Peptide SR25 has Broad Antimicrobial Activity and Potential Application for Healing Bacteria‐infected Diabetic Wounds. Advanced Science. 2024;11(30). doi:10.1002/advs.202401793

BibTeX
@article{Luo2024,
  author = {Luo, Xue-Yue and Hu, Chun-Mei and Yin, Qi and Zhang, Xiao-Mei and Liu, Zhen-Zhen and Zhou, Cheng-Kai and Zhang, Jian-Gang and Chen, Wei and Yang, Yong-Jun},
  title = {Dual‐Mechanism Peptide SR25 has Broad Antimicrobial Activity and Potential Application for Healing Bacteria‐infected Diabetic Wounds},
  journal = {Advanced Science},
  year = {2024},
  volume = {11},
  number = {30},
  doi = {10.1002/advs.202401793}
}
Kostenlos starten →